• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Replimune Group Inc (NQ: REPL )

    12.02 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Replimune Group Inc

    < Previous 1 2 Next >
    Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
    From Replimune Group Inc
    Via GlobeNewswire
    REPL Stock Earnings: Replimune Group Beats EPS for Q1 2025
    REPL stock results show that Replimune Group beat analyst estimates for earnings per share the first quarter of 2025. 
    Via InvestorPlace
    Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Replimune Group: Q3 Earnings Insights
    Via Benzinga
    Barclays Maintains Overweight Rating for Replimune Group: Here's What You Need To Know
    Via Benzinga
    Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday?
    Replimune reported that the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma showed a 33.6% response rate, with all responses lasting over six months. The treatment was... 
    Via Benzinga
    The Latest Analyst Ratings for Replimune Group
    Via Benzinga
    Analyst Ratings for Replimune Group
    Via Benzinga
    Replimune Group Inc. (NASDAQ: REPL) Making Surprising Moves in Monday Session
    Via Investor Brand Network
    J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    REPL Stock Earnings: Replimune Group Misses EPS for Q4 2024
    REPL stock results show that Replimune Group missed analyst estimates for earnings per share the fourth quarter of 2024. 
    Via InvestorPlace
    Crude Oil Moves Lower; AutoZone Profit Tops Views
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. 
    Via Benzinga
    Recap: Replimune Group Q4 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Dow Falls 100 Points; ISM Services PMI Increases In November
    U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.28% to 36,103.52 while the NASDAQ rose 0.32% to 14,230.64. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Replimune (REPL) Stock Down 48% Today?
    Replimune stock is dropping on Tuesday as investors in REPL shares react to a clinical trial missing both of its primary endpoints. 
    Via InvestorPlace
    US Stocks Down; JM Smucker Posts Upbeat Earnings
    U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 36,120.88 while the NASDAQ fell... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What's Going On With Cancer-Focused Replimune Stock Today?
    Replimune Group Inc (NASDAQ: REPL) announced results from the primary analysis of the CERPASS trial evaluating RP1 in combination with cemiplimab for locally advanced or metastatic cutaneous  
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    8 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
    From Incyte
    Via Business Wire
    Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
    The Nasdaq held near 52-week highs while small caps ramped up. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. 
    Via Benzinga
    ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
    ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference. 
    Via Investor's Business Daily
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.